TWELVE BIO
Twelve Bio is a developer of CRISPR-Cas12a diagnostic technology can detect and change any DNA sequence. CRISPR-Cas12a is an RNA-protein molecule that allow us to identify and modify specific DNA sequences. The RNA works like a search engine that identifies the specific DNA sequence and the protein is the biological scissor that cuts it.
TWELVE BIO
Social Links:
Industry:
Biotechnology Health Diagnostics Predictive Analytics
Founded:
2019-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.twelve.bio
Total Employee:
1+
Status:
Active
Contact:
+45 31 33 35 44
Email Addresses:
[email protected]
Total Funding:
519 K USD
Technology used in webpage:
SPF Microsoft Exchange Online Google Office 365 Mail Google Cloud Microsoft Azure DNS GoDaddy DNS Apple ICloud Mail Google Cloud South Carolina
Similar Organizations
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Medicus AI
Medicus AI designs and develops an artificial intelligence (AI) based enterprise and app platform that bring meaning to health data.
PhAST Diagnostics
PhAST Diagnostics develops rapid diagnostic technology to provide actionable information on pathogens.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Employees Featured
Founder
Official Site Inspections
http://www.twelve.bio
- Host name: 63.2.231.35.bc.googleusercontent.com
- IP address: 35.231.2.63
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Twelve Bio"
Twelve bio Company Profile 2024: Valuation, Investors …
Twelve bio General Information Description. Developer of a CRISPR diagnostic technology designed to detect early-stage lung cancer. The company's diagnostic test can identify lung cancer from a blood test and a gene-editing toolbox to …See details»
Twelve Bio - Company Profile - Tracxn
Nov 21, 2024 Twelve Bio is a developer of CRISPER technology-based diagnostics and therapeutics. CRISPR-Cas12a protein is a biological scissor for a DNA sequence. The …See details»
Twelve Bio - Org Chart, Teams, Culture & Jobs - The Org
View Twelve Bio's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Twelve Bio - LinkedIn
Twelve Bio was acquired by Ensoma in February 2023. Ensoma is based out of Boston, MA, with a research facility and office in Copenhagen, Denmark. We are integrating Twelve Bio’s …See details»
Ensoma Announces Closing of Twelve Bio Acquisition – Ensoma
Feb 9, 2023 Ensoma Announces Closing of Twelve Bio Acquisition. BOSTON, February 9, 2023 – Ensoma, a genomic medicines company developing one-time in vivo treatments that …See details»
Twelve Bio - Funding, Financials, Valuation & Investors - Crunchbase
Twelve Bio is a developer of CRISPR-Cas12a diagnostic technology can detect and change any DNA sequence. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How …See details»
Twelve Bio - Products, Competitors, Financials, Employees, …
Twelve Bio is a gene editing company that develops a CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) diagnostic technology to help detect early-stage lung cancer. It …See details»
Twelve Bio - Ownership and Business Overview - Mergr
Jan 5, 2024 Twelve Bio is a gene editing company pioneering the therapeutic application of next-generation CRISPR-Cas technology. The company has advanced foundational insights …See details»
Ensoma acquires Twelve Bio - 2023-01-05 - Crunchbase
Jan 5, 2023 Acquired Organization: Twelve Bio Twelve Bio is a developer of CRISPR-Cas12a diagnostic technology can detect and change any DNA sequence. Acquiring Organization: …See details»
Twelve Bio Company Profile - Office Locations, Competitors ... - Craft
Twelve Bio Summary. Company Summary. Overview. Twelve Bio is a company that develops CRISPR-Cas12. It is a diagnostic technology that can detect and change DNA sequences. …See details»
BII News - Meet the start-ups: Twelve Bio - BioInnovation Institute
Oct 25, 2019 Meet the start-ups: Twelve Bio. October 25, 2019 . The biotech start-up Twelve Bio is part of the fall run of the Business Acceleration Academy. Their current focus is the unmet …See details»
Twelve Bio - Contacts, Employees, Board Members, Advisors
Twelve Bio is a developer of CRISPR-Cas12a diagnostic technology can detect and change any DNA sequence.See details»
Twelve Bio - Founders and Board of Directors - Tracxn
Oct 14, 2024 Twelve Bio's founders include Stefano Stella and Guillermo Montoya. Their board of directors include Christian Schetter, John Cassidy and 2 others.See details»
Company: Twelve Bio
Website: https://twelve.bio/ Twelve Bio is a pre-clinical stage gene-editing company that primarily focuses on the Cas12a enzyme. The company is located in Copenhagen, Denmark, as part of …See details»
Twelve Bio - EU-Startups
Twelve Bio is a developer of CRISPR-Cas12a diagnostic technology can detect and change any DNA sequence. CRISPR-Cas12a is an RNA-protein molecule that allow us to identify and …See details»
TwelveBio - Arix Bioscience
Twelve Bio was founded based on research conducted at the Novo Nordisk Foundation (NNF) Center for Protein Research at the University of Copenhagen. With support from the Creation …See details»
Twelve Bio - Crunchbase
Twelve Bio is a developer of CRISPR-Cas12a diagnostic technology can detect and change any DNA sequence.See details»
Cas12a: Engineering superior tools for the CRISPR ... - CRISPR …
Jan 8, 2020 Twelve BIO was established in September 2019 at the Bio Innovation Institute (BII), thanks to a Bio Accelerator academy grant of 250.000 DKK, by its scientific co-founders …See details»
Twelve Bio - Updates, News, Events, Signals & Triggers - Crunchbase
Twelve Bio is a developer of CRISPR-Cas12a diagnostic technology can detect and change any DNA sequence.See details»